Skip to main navigation
  • News
  • Contact
Galera Therapeutics, Inc. logo
  • Company
    • About
    • Our Team
    • Board of Directors
  • Science
    • Our Science
    • Radiotherapy-Induced Toxicity
    • Radiotherapy Anti-Cancer Efficacy
    • Scientific Publications
  • Pipeline
    • Our Pipeline
    • Clinical Trials
  • Patients & Caregivers
  • Investors
    • IR Home
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Shareholder Services
  • Careers
  • Contact
Galera Therapeutics, Inc. Investor Relations header background image

Event Details

Galera ROMAN Phase 3 Trial Update

Dec 14, 2021 8:30 AM EST

Click here for webcast

Supporting Materials

View Presentation 1.8 MB
  • IR Home
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • SEC Filings
  • Shareholder Services
Galera Therapeutics, Inc. logo

Galera Therapeutics, Inc.

45 Liberty Blvd, Suite 230
Malvern, PA 19355

610-725-1500

info@galeratx.com

Visit us on Twitter Visit us on LinkedIn

©2023 Galera Therapeutics, Inc. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • Expanded Access Policy